Skip to content
Thursday, May 14, 2026
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2023
  • July
  • 28
  • AstraZeneca Q2 results beat estimates; COVID vaccine sales dry up
  • FILE PHOTO: FILE PHOTO: The company logo for pharmaceutical company

    FILE PHOTO: FILE PHOTO: The company logo for pharmaceutical company

    FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

    Post navigation

    Previous: AstraZeneca Q2 results beat estimates; COVID vaccine sales dry up

    Live Market Pulse

    The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

    Sign up for our free The Cheap Investor Newsletter!

    Discover new market trends and ideas directly to your inbox.

    ✅ You're in! Check your inbox soon.

    By submitting your email address, you'll receive a free subscription to The Cheap Investor newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

    Recent Posts

    • The Day the Dow Hit 50,000 (Again)
    • RAD Intel is 95%+ allocated. Act now.
    • Jon Najarian recently concluded something truly shocking…
    • Cisco Woke Up
    • This Pre-IPO Window Is Closing Tomorrow
    • NVDA May 20: Good Enough Won’t Be Good Enough
    • When Inflation Crashes the AI Party
    • When Inflation Crashes the AI Party

    Categories

    • Headlines
    • Business
    • Economy
    • Politics
    • Top News
    • Newsletters

    • Home
    • Disclaimer
    • Contact Us
    • Terms of Service
    • Privacy Policy
    Copyright 2026 © All rights reserved | The Cheap Investor | thecheapinvestor.com
    SITE_OK